Herbalife: Profound victory for HLF - Pivotal Research
This is a total victory for Herbalife shareholders and a total defeat for the short camp. Leaving aside the potential for a short squeeze that could take the stock to breathtaking levels in the short run, they believe the deal with the FTC is effectively the "all-clear" for HLF and indeed, USANA Health Sciences (USNA -- BUY - $122.26) PT $160; and Nu Skin Enterprises (NUS -- BUY - $49.91) PT $60. Thus they expect the stock to re-price rather rapidly to the $80-$100 level.